Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma

NCT02774421 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02774421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Completed
Start date
June 12, 2017
Completion date
March 31, 2026
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posterior fossa ependymoma (pfepn)